Further, expression changes throughout disease progression were explored for each DEG using Oncomine, which demonstrated increased expression of cyclin-dependent kinase 1 (CDK1) and centrosomal protein 55 (CEP55) as PC progresses. This evidence concerns the gene CDK1 and pachyonychia congenita.